id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02341287 | 14:37:chronic_disease | History of a dermatological disorder | 2 | [
"History",
"of",
"a",
"dermatological",
"disorder"
] | [
0,
0,
0,
2,
2
] |
NCT03088709 | 1:12:chronic_disease | Hepatitis C | 2 | [
"Hepatitis",
"C"
] | [
2,
2
] |
NCT02562066 | 1:39:treatment,52:75:treatment,78:84:treatment,89:105:treatment, | Treatment with an investigational drug (other than amifampridine phosphate), device, or biological agent within 30 days before Screening or while participating in this study | 2 | [
"Treatment",
"with",
"an",
"investigational",
"drug",
"(",
"other",
"than",
"amifampridine",
"phosphate",
")",
",",
"device",
",",
"or",
"biological",
"agent",
"within",
"30",
"days",
"before",
"Screening",
"or",
"while",
"participating",
"in",
"this",
"study"
] | [
1,
1,
1,
1,
1,
0,
0,
0,
1,
1,
0,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02372006 | 29:36:chronic_disease,39:46:chronic_disease,48:53:chronic_disease,55:78:chronic_disease,80:83:chronic_disease,85:94:chronic_disease | known pre-existing relevant cardiac , hepatic, renal, bone marrow dysfunction, ILD, keratitis | 2 | [
"known",
"pre-existing",
"relevant",
"cardiac",
",",
"hepatic",
",",
"renal",
",",
"bone",
"marrow",
"dysfunction",
",",
"ILD",
",",
"keratitis"
] | [
0,
0,
0,
2,
0,
2,
0,
2,
0,
2,
2,
2,
0,
2,
0,
2
] |
NCT02923011 | 33:72:allergy_name | Known intolerance or allergy to MR contrast agent (gadolinium chelates) | 2 | [
"Known",
"intolerance",
"or",
"allergy",
"to",
"MR",
"contrast",
"agent",
"(",
"gadolinium",
"chelates",
")"
] | [
0,
0,
0,
0,
0,
4,
4,
4,
4,
4,
0,
0
] |
NCT02931110 | 19:24:cancer,26:28:cancer,30:33:cancer,35:37:cancer,42:45:cancer,46:49:cancer,, | For subjects with DLBCL, FL, MCL, HL, or CLL/SLL: presence of radiographically measurable lymphadenopathy or extranodal lymphoid malignancy (defined as the presence of ≥1 lesion that measures ≥2.0 cm in the longest dimension [LD] and ≥1.0 cm in the longest perpendicular dimension [LPD] as assessed by computed tomograph... | 2 | [
"For",
"subjects",
"with",
"DLBCL",
",",
"FL",
",",
"MCL",
",",
"HL",
",",
"or",
"CLL/SLL",
":",
"presence",
"of",
"radiographically",
"measurable",
"lymphadenopathy",
"or",
"extranodal",
"lymphoid",
"malignancy",
"(",
"defined",
"as",
"the",
"presence",
"of",... | [
0,
0,
0,
3,
0,
3,
0,
3,
0,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03070899 | 13:38:chronic_disease | Undiagnosed abnormal uterine bleeding | 2 | [
"Undiagnosed",
"abnormal",
"uterine",
"bleeding"
] | [
0,
2,
2,
2
] |
NCT02950233 | 1:24:chronic_disease,, | Severe renal impairment (creatinine clearance based GFR of <30ml/min) | 2 | [
"Severe",
"renal",
"impairment",
"(",
"creatinine",
"clearance",
"based",
"GFR",
"of",
"<",
"30ml/min",
")"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02905929 | 8:27:treatment | Use of insulin medications | 2 | [
"Use",
"of",
"insulin",
"medications"
] | [
0,
0,
1,
1
] |
NCT02477826 | 23:40:chronic_disease,44:61:chronic_disease,65:99:chronic_disease,111:137:chronic_disease | Any positive test for hepatitis B virus or hepatitis C virus or human immunodeficiency virus (HIV) indicating acute or chronic infection | 2 | [
"Any",
"positive",
"test",
"for",
"hepatitis",
"B",
"virus",
"or",
"hepatitis",
"C",
"virus",
"or",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"indicating",
"acute",
"or",
"chronic",
"infection"
] | [
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2
] |
NCT02366871 | 1:21:chronic_disease | protein C deficiency | 2 | [
"protein",
"C",
"deficiency"
] | [
2,
2,
2
] |
NCT02665338 | 10:25:chronic_disease | Unstable cardiac disease | 2 | [
"Unstable",
"cardiac",
"disease"
] | [
0,
2,
2
] |
NCT02406599 | 28:42:treatment | Patients for whom complete cavity shaving is planned (sites where this is the routine practice of the investigator will also be excluded from participation in the study) | 2 | [
"Patients",
"for",
"whom",
"complete",
"cavity",
"shaving",
"is",
"planned",
"(",
"sites",
"where",
"this",
"is",
"the",
"routine",
"practice",
"of",
"the",
"investigator",
"will",
"also",
"be",
"excluded",
"from",
"participation",
"in",
"the",
"study",
")"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02252432 | 15:42:treatment | scheduled for elective lumbar laminectomy | 2 | [
"scheduled",
"for",
"elective",
"lumbar",
"laminectomy"
] | [
0,
0,
1,
1,
1
] |
NCT02629731 | 14:30:chronic_disease | diagnosis of ankle OA or PTTD [non-control subjects only] | 2 | [
"diagnosis",
"of",
"ankle",
"OA",
"or",
"PTTD",
"[",
"non-control",
"subjects",
"only",
"]"
] | [
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT01886794 | 12:37:chronic_disease | History of connective tissue disease | 2 | [
"History",
"of",
"connective",
"tissue",
"disease"
] | [
0,
0,
2,
2,
2
] |
NCT03108950 | 1:14:chronic_disease | Renal failure | 2 | [
"Renal",
"failure"
] | [
2,
2
] |
NCT03060473 | 1:20:chronic_disease | placental abruption | 2 | [
"placental",
"abruption"
] | [
2,
2
] |
NCT02806570 | 8:30:chronic_disease | Active bacterial endocarditis | 2 | [
"Active",
"bacterial",
"endocarditis"
] | [
0,
2,
2
] |
NCT00001651 | 12:25:chronic_disease | Documented HIV infection (ELISA/Western blot positive or, for acute seroconverters, PCR positive) | 2 | [
"Documented",
"HIV",
"infection",
"(",
"ELISA/Western",
"blot",
"positive",
"or",
",",
"for",
"acute",
"seroconverters",
",",
"PCR",
"positive",
")"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02501473 | 12:17:cancer,42:64:treatment,85:94:treatment | Measurable tumor mass(es) accessible for intratumoral injection must be present for treatment and assessment of response | 2 | [
"Measurable",
"tumor",
"mass",
"(",
"es",
")",
"accessible",
"for",
"intratumoral",
"injection",
"must",
"be",
"present",
"for",
"treatment",
"and",
"assessment",
"of",
"response"
] | [
0,
3,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT00720785 | 1:8:cancer,78:87:treatment,93:103:treatment | Myeloma patients are required to have disease which has progressed following treatment with bortezomib | 2 | [
"Myeloma",
"patients",
"are",
"required",
"to",
"have",
"disease",
"which",
"has",
"progressed",
"following",
"treatment",
"with",
"bortezomib"
] | [
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT00902720 | 1:15:treatment | drug treatment | 2 | [
"drug",
"treatment"
] | [
1,
1
] |
NCT02871349 | 7:18:chronic_disease | Major head trauma | 2 | [
"Major",
"head",
"trauma"
] | [
0,
2,
2
] |
NCT02474927 | 25:36:treatment | Previous intolerance to carfilzomib | 2 | [
"Previous",
"intolerance",
"to",
"carfilzomib"
] | [
0,
0,
0,
1
] |
NCT02620449 | 1:14:chronic_disease,,,,, | severe anemia (hemoglobin < 8 g/dl for women and < 9 g/dl for men) | 2 | [
"severe",
"anemia",
"(",
"hemoglobin",
"<",
"8",
"g/dl",
"for",
"women",
"and",
"<",
"9",
"g/dl",
"for",
"men",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00924027 | 36:43:treatment,58:67:treatment,94:112:cancer | Patients who are unable to undergo surgery and must have treatment for an inoperable primary endometrial cancer | 2 | [
"Patients",
"who",
"are",
"unable",
"to",
"undergo",
"surgery",
"and",
"must",
"have",
"treatment",
"for",
"an",
"inoperable",
"primary",
"endometrial",
"cancer"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
3,
3
] |
NCT02365467 | 3:20:chronic_disease,,, | a fusiform aneurysm with a diameter of ≥ 5.5 cm OR is > 2 times the diameter of the non-aneurysmal thoracic aorta | 2 | [
"a",
"fusiform",
"aneurysm",
"with",
"a",
"diameter",
"of",
"≥",
"5.5",
"cm",
"OR",
"is",
">",
"2",
"times",
"the",
"diameter",
"of",
"the",
"non-aneurysmal",
"thoracic",
"aorta"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02554786 | 14:20:chronic_disease, | diagnosis of asthma, for a period of at least 1 year prior to Visit 1 (Screening) | 2 | [
"diagnosis",
"of",
"asthma",
",",
"for",
"a",
"period",
"of",
"at",
"least",
"1",
"year",
"prior",
"to",
"Visit",
"1",
"(",
"Screening",
")"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02656550 | 28:34:cancer, | Subject who has history of cancer in last five years | 2 | [
"Subject",
"who",
"has",
"history",
"of",
"cancer",
"in",
"last",
"five",
"years"
] | [
0,
0,
0,
0,
0,
3,
0,
0,
0,
0
] |
NCT00230607 | 24:38:treatment | agree to adhere to the Fabry Registry recommended schedule of assessments for medical history | 2 | [
"agree",
"to",
"adhere",
"to",
"the",
"Fabry",
"Registry",
"recommended",
"schedule",
"of",
"assessments",
"for",
"medical",
"history"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02953509 | 25:51:chronic_disease | Known active or chronic hepatitis B or C infection | 2 | [
"Known",
"active",
"or",
"chronic",
"hepatitis",
"B",
"or",
"C",
"infection"
] | [
0,
0,
0,
0,
2,
2,
2,
2,
2
] |
NCT02570854 | 15:38:chronic_disease | Patients with Hepatitis C Virus (HCV) infection may be included if all other liver function eligibility criteria are met | 2 | [
"Patients",
"with",
"Hepatitis",
"C",
"Virus",
"(",
"HCV",
")",
"infection",
"may",
"be",
"included",
"if",
"all",
"other",
"liver",
"function",
"eligibility",
"criteria",
"are",
"met"
] | [
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00632853 | 10:46:treatment | No prior mediastinal or thoracic radiotherapy | 2 | [
"No",
"prior",
"mediastinal",
"or",
"thoracic",
"radiotherapy"
] | [
0,
0,
1,
1,
1,
1
] |
NCT00881660 | 18:21:chronic_disease | Extremely Severe CDH | 2 | [
"Extremely",
"Severe",
"CDH"
] | [
0,
0,
2
] |
NCT02382419 | 1:75:cancer,90:120:chronic_disease,206:229:treatment | Normal Pap or Atypical Squamous Cells of Undetermined Significance (ASCUS) Pap test with HPV deoxyribonucleic acid (DNA) negative by reflex testing via Hybrid Capture 2 (Digene Corp., Gaithersburg, MD), a standard clinical assay within clinically acceptable screening guidelines (American Cancer Society [ACS]/American S... | 2 | [
"Normal",
"Pap",
"or",
"Atypical",
"Squamous",
"Cells",
"of",
"Undetermined",
"Significance",
"(",
"ASCUS",
")",
"Pap",
"test",
"with",
"HPV",
"deoxyribonucleic",
"acid",
"(",
"DNA",
")",
"negative",
"by",
"reflex",
"testing",
"via",
"Hybrid",
"Capture",
"2",
... | [
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02367040 | 1:24:cancer,, | Follicular lymphoma(FL) grade1-2-3a | 2 | [
"Follicular",
"lymphoma",
"(",
"FL",
")",
"grade1-2-3a"
] | [
3,
3,
0,
0,
0,
0
] |
NCT02270970 | 5:31:treatment,73:90:treatment,81:90:treatment | any immune suppressive therapy being taken despite option for immediate steroid treatment and later treatment rescues as needed | 2 | [
"any",
"immune",
"suppressive",
"therapy",
"being",
"taken",
"despite",
"option",
"for",
"immediate",
"steroid",
"treatment",
"and",
"later",
"treatment",
"rescues",
"as",
"needed"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02124902 | 19:25:cancer | Patients with PR+ tumors are allowed | 2 | [
"Patients",
"with",
"PR+",
"tumors",
"are",
"allowed"
] | [
0,
0,
0,
3,
0,
0
] |
NCT02471911 | ,,,122:150:treatment | Women of childbearing potential must agree to use dual methods of contraception and have a negative serum pregnancy test prior to selinexor treatment | 2 | [
"Women",
"of",
"childbearing",
"potential",
"must",
"agree",
"to",
"use",
"dual",
"methods",
"of",
"contraception",
"and",
"have",
"a",
"negative",
"serum",
"pregnancy",
"test",
"prior",
"to",
"selinexor",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT01943851 | 35:60:chronic_disease | there are no signs or symptoms of graft versus host disease, other than Grade 1 skin involvement | 2 | [
"there",
"are",
"no",
"signs",
"or",
"symptoms",
"of",
"graft",
"versus",
"host",
"disease",
",",
"other",
"than",
"Grade",
"1",
"skin",
"involvement"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02547662 | ,43:55:treatment,,,,213:222:treatment,294:315:treatment | at least 28 days before she starts taking pomalidomide FCBP must also agree to ongoing pregnancy testing; men must agree to use a latex condom during sexual contact with a FCBP even if they have had a successful vasectomy; patient must follow pregnancy testing requirements as outlined in the POMALYST REMS program | 2 | [
"at",
"least",
"28",
"days",
"before",
"she",
"starts",
"taking",
"pomalidomide",
"FCBP",
"must",
"also",
"agree",
"to",
"ongoing",
"pregnancy",
"testing",
";",
"men",
"must",
"agree",
"to",
"use",
"a",
"latex",
"condom",
"during",
"sexual",
"contact",
"with... | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01966367 | 42:65:cancer | Additional eligibility for patients with non-malignant disorders receiving reduced intensity conditioning | 2 | [
"Additional",
"eligibility",
"for",
"patients",
"with",
"non-malignant",
"disorders",
"receiving",
"reduced",
"intensity",
"conditioning"
] | [
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0
] |
NCT02426047 | 14:36:chronic_disease | Metabolic or mitochondrial disorder | 2 | [
"Metabolic",
"or",
"mitochondrial",
"disorder"
] | [
0,
0,
2,
2
] |
NCT02513797 | ,56:69:chronic_disease | Currently exhibits New York Heart Association Class IV heart failure symptoms | 2 | [
"Currently",
"exhibits",
"New",
"York",
"Heart",
"Association",
"Class",
"IV",
"heart",
"failure",
"symptoms"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT02742454 | 67:86:chronic_disease | Medical emergency necessitating emergency delivery (e.g. complete placental abruption) | 2 | [
"Medical",
"emergency",
"necessitating",
"emergency",
"delivery",
"(",
"e.g",
".",
"complete",
"placental",
"abruption",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT01928576 | 79:90:treatment,96:106:treatment,114:123:treatment,, | Because no dosing or adverse event data are currently available on the use of azacitidine with entinostat, or of Nivolumab, in patients <18 years of age, children are excluded from this study | 2 | [
"Because",
"no",
"dosing",
"or",
"adverse",
"event",
"data",
"are",
"currently",
"available",
"on",
"the",
"use",
"of",
"azacitidine",
"with",
"entinostat",
",",
"or",
"of",
"Nivolumab",
",",
"in",
"patients",
"<",
"18",
"years",
"of",
"age",
",",
"childre... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01823198 | 19:47:cancer | Treatment related acute myeloid leukemia (AML) | 2 | [
"Treatment",
"related",
"acute",
"myeloid",
"leukemia",
"(",
"AML",
")"
] | [
0,
0,
3,
3,
3,
3,
0,
0
] |
NCT02667418 | 11:26:chronic_disease | incipient toxic megacolon | 2 | [
"incipient",
"toxic",
"megacolon"
] | [
0,
2,
2
] |
NCT01730118 | ,,,,,,,,271:289:cancer | Chemistry parameters: Creatinine less than 1.5 mg/dL, SGOT and SGPT less than or equal to 3X the upper limits of normal and total bilirubin less than or equal to 1.5 mg/dl, Alk PO4 less than or equal to 3X the upper limits of normal (except for patients with documented metastatic disease to bone and/or liver) | 2 | [
"Chemistry",
"parameters",
":",
"Creatinine",
"less",
"than",
"1.5",
"mg/dL",
",",
"SGOT",
"and",
"SGPT",
"less",
"than",
"or",
"equal",
"to",
"3X",
"the",
"upper",
"limits",
"of",
"normal",
"and",
"total",
"bilirubin",
"less",
"than",
"or",
"equal",
"to",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0
] |
NCT01990209 | 1:26:treatment,,55:64:treatment,68:93:treatment, | Major surgical procedures ≤28 days of beginning study treatment or minor surgical procedures ≤7 days | 2 | [
"Major",
"surgical",
"procedures",
"≤28",
"days",
"of",
"beginning",
"study",
"treatment",
"or",
"minor",
"surgical",
"procedures",
"≤7",
"days"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
0,
0
] |
NCT02446236 | ,,,,,,149:160:chronic_disease, | Platelets > 75,000/μL and absolute neutrophils count (ANC) > 1,000/μL within 14 days of study registration (unless the treating physician deems the neutropenia is related to bone marrow involvement, then an ANC of > 750/mm 3 is allowed) | 2 | [
"Platelets",
">",
"75,000/μL",
"and",
"absolute",
"neutrophils",
"count",
"(",
"ANC",
")",
">",
"1,000/μL",
"within",
"14",
"days",
"of",
"study",
"registration",
"(",
"unless",
"the",
"treating",
"physician",
"deems",
"the",
"neutropenia",
"is",
"related",
"t... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02252588 | 32:45:chronic_disease | Presence or high likelihood of chronic cough and sputum production | 2 | [
"Presence",
"or",
"high",
"likelihood",
"of",
"chronic",
"cough",
"and",
"sputum",
"production"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0
] |
NCT03104699 | 1:9:treatment | Steroids with no or minimal systemic effect (topical, inhalation) | 2 | [
"Steroids",
"with",
"no",
"or",
"minimal",
"systemic",
"effect",
"(",
"topical",
",",
"inhalation",
")"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03096418 | 24:42:cancer | Patients must not have metastatic disease on staging work-up with CBC and liver function studies | 2 | [
"Patients",
"must",
"not",
"have",
"metastatic",
"disease",
"on",
"staging",
"work-up",
"with",
"CBC",
"and",
"liver",
"function",
"studies"
] | [
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01894061 | ,53:100:treatment | 3 weeks must have elapsed since the completion of a non-nitrosourea-containing chemotherapy regimen | 2 | [
"3",
"weeks",
"must",
"have",
"elapsed",
"since",
"the",
"completion",
"of",
"a",
"non-nitrosourea-containing",
"chemotherapy",
"regimen"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02650206 | 31:55:cancer | Personal or family history of medullary thyroid cancer | 2 | [
"Personal",
"or",
"family",
"history",
"of",
"medullary",
"thyroid",
"cancer"
] | [
0,
0,
0,
0,
0,
3,
3,
3
] |
NCT00594217 | ,12:16:chronic_disease,62:78:chronic_disease,84:98:chronic_disease,131:147:chronic_disease | women with PCOS (defined as clinical/biochemical evidence of hyperandrogenism plus oligomenorrhea, but with no evidence for other endocrinopathies) | 2 | [
"women",
"with",
"PCOS",
"(",
"defined",
"as",
"clinical/biochemical",
"evidence",
"of",
"hyperandrogenism",
"plus",
"oligomenorrhea",
",",
"but",
"with",
"no",
"evidence",
"for",
"other",
"endocrinopathies",
")"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT02474368 | 1:4:chronic_disease,41:63:treatment,128:153:treatment,155:159:treatment,164:190:treatment | HIV-positive individuals on combination antiretroviral therapy are ineligible because of the potential for interaction between conventional radiotherapy, SBRT and antiretroviral medications | 2 | [
"HIV-positive",
"individuals",
"on",
"combination",
"antiretroviral",
"therapy",
"are",
"ineligible",
"because",
"of",
"the",
"potential",
"for",
"interaction",
"between",
"conventional",
"radiotherapy",
",",
"SBRT",
"and",
"antiretroviral",
"medications"
] | [
2,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0
] |
NCT01920061 | ,4:78:treatment | >2 prior regimens containing cytotoxic chemotherapy in the metastatic setting | 2 | [
">",
"2",
"prior",
"regimens",
"containing",
"cytotoxic",
"chemotherapy",
"in",
"the",
"metastatic",
"setting"
] | [
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT00001651 | 79:93:treatment | Adequate venous access in the arms for blood drawing and 5 day infusions, and lymphapheresis | 2 | [
"Adequate",
"venous",
"access",
"in",
"the",
"arms",
"for",
"blood",
"drawing",
"and",
"5",
"day",
"infusions",
",",
"and",
"lymphapheresis"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02418195 | 1:12:chronic_disease | Scleroderma | 2 | [
"Scleroderma"
] | [
2
] |
NCT03036254 | ,35:39:treatment | Chest pathology incompatible with HBOT | 2 | [
"Chest",
"pathology",
"incompatible",
"with",
"HBOT"
] | [
0,
0,
0,
0,
1
] |
NCT02582905 | ,,,,,51:60:chronic_disease,51:58:chronic_disease,64:75:chronic_disease,79:103:chronic_disease | Outpatient men and women age 18-70 years old with bipolar I or II disorder or schizoaffective disorder (bipolar type) | 2 | [
"Outpatient",
"men",
"and",
"women",
"age",
"18-70",
"years",
"old",
"with",
"bipolar",
"I",
"or",
"II",
"disorder",
"or",
"schizoaffective",
"disorder",
"(",
"bipolar",
"type",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0
] |
NCT02064296 | 1:12:treatment, | Acupuncture within last 6-months | 2 | [
"Acupuncture",
"within",
"last",
"6-months"
] | [
1,
0,
0,
0
] |
NCT02390752 | 1:27:chronic_disease | Active untreated infection | 2 | [
"Active",
"untreated",
"infection"
] | [
2,
2,
2
] |
NCT02487095 | 20:38:chronic_disease | Patients must have measurable disease, per RECIST 1.1. Subjects with evaluable, but not measurable disease will be eligible for Phase 1 | 2 | [
"Patients",
"must",
"have",
"measurable",
"disease",
",",
"per",
"RECIST",
"1.1",
".",
"Subjects",
"with",
"evaluable",
",",
"but",
"not",
"measurable",
"disease",
"will",
"be",
"eligible",
"for",
"Phase",
"1"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03070535 | 54:72:treatment | Acid reflux is allowed if participant is on a stable medication regimen | 2 | [
"Acid",
"reflux",
"is",
"allowed",
"if",
"participant",
"is",
"on",
"a",
"stable",
"medication",
"regimen"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02480036 | 1:21:treatment | Previous kyphoplasty in the same area | 2 | [
"Previous",
"kyphoplasty",
"in",
"the",
"same",
"area"
] | [
1,
1,
0,
0,
0,
0
] |
NCT02472834 | 20:46:treatment, | Taking any type of amino acid supplementation within the last 90 days | 2 | [
"Taking",
"any",
"type",
"of",
"amino",
"acid",
"supplementation",
"within",
"the",
"last",
"90",
"days"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02465060 | 27:40:treatment,,86:94:chronic_disease,99:110:chronic_disease,124:133:treatment | all adverse events due to prior therapy have resolved to a grade 1 or better (except alopecia and lymphopenia) by start of treatment | 2 | [
"all",
"adverse",
"events",
"due",
"to",
"prior",
"therapy",
"have",
"resolved",
"to",
"a",
"grade",
"1",
"or",
"better",
"(",
"except",
"alopecia",
"and",
"lymphopenia",
")",
"by",
"start",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
0,
0,
1
] |
NCT02310399 | 27:46:chronic_disease,48:61:chronic_disease,63:76:chronic_disease | Patients with evidence of Chiari malformation, hydrocephalus, spina bifid a | 2 | [
"Patients",
"with",
"evidence",
"of",
"Chiari",
"malformation",
",",
"hydrocephalus",
",",
"spina",
"bifid",
"a"
] | [
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
2,
2
] |
NCT02490943 | 1:18:chronic_disease | Bleeding disorder | 2 | [
"Bleeding",
"disorder"
] | [
2,
2
] |
NCT02796391 | 1:23:treatment | Irinotecan (Camptosar) | 2 | [
"Irinotecan",
"(",
"Camptosar",
")"
] | [
1,
1,
0,
0
] |
NCT02118610 | 21:34:chronic_disease | DSM-IV diagnosis of schizophrenia | 2 | [
"DSM-IV",
"diagnosis",
"of",
"schizophrenia"
] | [
0,
0,
0,
2
] |
NCT01865162 | 1:29:treatment | non-cytotoxic hormonal agent | 2 | [
"non-cytotoxic",
"hormonal",
"agent"
] | [
1,
1,
1
] |
NCT02498301 | ,94:105:treatment | Subject is currently taking or plans to take during deployment at least one of the following medications | 2 | [
"Subject",
"is",
"currently",
"taking",
"or",
"plans",
"to",
"take",
"during",
"deployment",
"at",
"least",
"one",
"of",
"the",
"following",
"medications"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02324582 | 1:28:treatment | Prior systemic chemotherapy | 2 | [
"Prior",
"systemic",
"chemotherapy"
] | [
1,
1,
1
] |
NCT01871727 | 93:110:treatment | A shorter washout may be allowed if participant is experiencing progressive disease despite ongoing treatment | 2 | [
"A",
"shorter",
"washout",
"may",
"be",
"allowed",
"if",
"participant",
"is",
"experiencing",
"progressive",
"disease",
"despite",
"ongoing",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03034564 | 1:17:chronic_disease | light headedness | 2 | [
"light",
"headedness"
] | [
2,
2
] |
NCT02416674 | 35:50:treatment | Strong motivation to proceed with transplantation | 2 | [
"Strong",
"motivation",
"to",
"proceed",
"with",
"transplantation"
] | [
0,
0,
0,
0,
0,
1
] |
NCT02004275 | 15:49:chronic_disease,50:59:chronic_disease | Patients with human immunodeficiency virus (HIV) infection are eligible | 2 | [
"Patients",
"with",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"infection",
"are",
"eligible"
] | [
0,
0,
2,
2,
2,
2,
0,
0,
2,
0,
0
] |
NCT03030859 | 18:24:cancer | any other active cancer | 2 | [
"any",
"other",
"active",
"cancer"
] | [
0,
0,
0,
3
] |
NCT02105766 | 16:34:treatment,143:167:chronic_disease,171:186:chronic_disease,206:212:chronic_disease | Fit to receive filgrastim (G-CSF) and to give peripheral blood stem cells (blood counts and blood pressure within DTM standards no history of congestive heart failure or unstable angina, and no history of stroke) | 2 | [
"Fit",
"to",
"receive",
"filgrastim",
"(",
"G-CSF",
")",
"and",
"to",
"give",
"peripheral",
"blood",
"stem",
"cells",
"(",
"blood",
"counts",
"and",
"blood",
"pressure",
"within",
"DTM",
"standards",
"no",
"history",
"of",
"congestive",
"heart",
"failure",
"... | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0
] |
NCT02516670 | 16:29:chronic_disease | Has history of iron overload | 2 | [
"Has",
"history",
"of",
"iron",
"overload"
] | [
0,
0,
0,
2,
2
] |
NCT02515110 | 27:29:chronic_disease,33:43:chronic_disease | Clinical nodal staging of N2 or N3 disease | 2 | [
"Clinical",
"nodal",
"staging",
"of",
"N2",
"or",
"N3",
"disease"
] | [
0,
0,
0,
0,
2,
0,
2,
2
] |
NCT02048332 | ,42:60:treatment | Recipient must be at least 28 days after stem cell infusion | 2 | [
"Recipient",
"must",
"be",
"at",
"least",
"28",
"days",
"after",
"stem",
"cell",
"infusion"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02021604 | 41:43:chronic_disease | Patients who do not have a diagnosis of HI | 2 | [
"Patients",
"who",
"do",
"not",
"have",
"a",
"diagnosis",
"of",
"HI"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02366754 | 23:30:chronic_disease, | Have had a documented seizure within 3 months of study screening | 2 | [
"Have",
"had",
"a",
"documented",
"seizure",
"within",
"3",
"months",
"of",
"study",
"screening"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02332369 | 1:21:chronic_disease | Congenital cataracts | 2 | [
"Congenital",
"cataracts"
] | [
2,
2
] |
NCT01532687 | 1:24:treatment | Injectable progesterone | 2 | [
"Injectable",
"progesterone"
] | [
1,
1
] |
NCT02333162 | 1:29:cancer,44:74:cancer,93:137:treatment | acute myeloid leukemia (AML) and high risk myelodysplastic syndrome (MDS) undergoing second allogeneic (allo)-stem cell transplant (SCT) using the same donor or different donor for disease relapse | 2 | [
"acute",
"myeloid",
"leukemia",
"(",
"AML",
")",
"and",
"high",
"risk",
"myelodysplastic",
"syndrome",
"(",
"MDS",
")",
"undergoing",
"second",
"allogeneic",
"(",
"allo",
")",
"-stem",
"cell",
"transplant",
"(",
"SCT",
")",
"using",
"the",
"same",
"donor",
... | [
3,
3,
3,
3,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03073785 | 62:70:cancer | Patients with inoperable conditions with resectable disease (T1-2NoMo) | 2 | [
"Patients",
"with",
"inoperable",
"conditions",
"with",
"resectable",
"disease",
"(",
"T1-2NoMo",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
0
] |
NCT02532595 | 1:17:treatment | Previous surgery to the foot/ankle | 2 | [
"Previous",
"surgery",
"to",
"the",
"foot/ankle"
] | [
1,
1,
0,
0,
0
] |
NCT02589353 | 18:22:allergy_name | has a history of food allergy | 2 | [
"has",
"a",
"history",
"of",
"food",
"allergy"
] | [
0,
0,
0,
0,
4,
0
] |
NCT02003222 | 1:4:chronic_disease | MRD results will be reported to the submitting institution | 2 | [
"MRD",
"results",
"will",
"be",
"reported",
"to",
"the",
"submitting",
"institution"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02451683 | 27:33:chronic_disease | History of head injury or stroke | 2 | [
"History",
"of",
"head",
"injury",
"or",
"stroke"
] | [
0,
0,
0,
0,
0,
2
] |
NCT02400255 | 1:64:treatment,71:103:treatment,105:128:treatment,133:190:treatment | First allogeneic hematopoietic stem cell transplantation (HSCT) using myeloablative conditioning (MAC), non-myeloablative (NMA), or reduced-intensity conditioning (RIC) preparative regimens | 2 | [
"First",
"allogeneic",
"hematopoietic",
"stem",
"cell",
"transplantation",
"(",
"HSCT",
")",
"using",
"myeloablative",
"conditioning",
"(",
"MAC",
")",
",",
"non-myeloablative",
"(",
"NMA",
")",
",",
"or",
"reduced-intensity",
"conditioning",
"(",
"RIC",
")",
"p... | [
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0
] |
NCT02843945 | 18:43:cancer | locally advanced pancreatic adenocarcinoma | 2 | [
"locally",
"advanced",
"pancreatic",
"adenocarcinoma"
] | [
0,
0,
3,
3
] |
NCT02004275 | 1:27:chronic_disease | Pomalidomide naive disease | 2 | [
"Pomalidomide",
"naive",
"disease"
] | [
2,
2,
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.